Zobrazeno 1 - 10
of 15
pro vyhledávání: '"J E, Alés"'
Autor:
E, Bouza, M, Martin, J E, Alés, N, Aragonés, B, Barragán, R, de la Cámara, J L, Del Pozo, V, García-Gutiérrez, R, García-Sanz, D, Gracia, V, Guillem, V, Jiménez-Yuste, M C, Martin-Delgado, J, Martínez, R, López, A, Rodríguez-Lescure, J, Ruiz Galiana, A M, Sureda, F, Tejerina-Picado, A, Trilla, A, Zapatero, E, Palomo, J, San-Miguel
Publikováno v:
Revista Española de Quimioterapia. 36:1-25
We do not know the precise figure for solid organ tumors diagnosed each year in Spain and it is therefore difficult to calculate whether there has been a decrease in cancer diagnoses as a consequence of the pandemic. Some indirect data suggest that t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::37724d32b210f7a40a2b22c71834966c
https://doi.org/10.37201/req/087.2022
https://doi.org/10.37201/req/087.2022
Autor:
S, González-Santiago, T, Ramón Y Cajal, E, Aguirre, J E, Alés-Martínez, R, Andrés, J, Balmaña, B, Graña, A, Herrero, G, Llort, A, González-Del-Alba
Publikováno v:
Scientia
Mama hereditaria; Cáncer de ovarios; Directrices SEOM Mama hereditària; Càncer d'ovaris; Directrius SEOM Hereditary breast; Ovarian cancer; SEOM guidelines Mutations in BRCA1 and BRCA2 high penetrance genes account for most hereditary breast and o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::281a3c39a45995b36c91b7d4f1c38f48
https://pubmed.ncbi.nlm.nih.gov/31889241
https://pubmed.ncbi.nlm.nih.gov/31889241
Publikováno v:
Clinical and Translational Oncology. 9:459-464
Cisplatin-gemcitabine is a synergistic chemotherapy (CT) combination highly proven in a broad spectrum of epithelial neoplasms and shows a non-cross-resistance profile with the most active drugs in metastatic breast cancer (MBC). We have conducted an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7d412947071f5702dde17aee4bfae76e
https://doi.org/10.1007/s12094-007-0085-5
https://doi.org/10.1007/s12094-007-0085-5
Publikováno v:
The EMBO Journal. 12:1555-1560
Programmed cell death (PCD) or apoptosis is a common form of cellular demise during embryogenesis, tumorigenesis and clonal selection in the immune system. The bcl-2 proto-oncogene has been recently implicated as a potential physiological regulator o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e3a3e384589885de5b30e46ddcf0a160
https://doi.org/10.1002/j.1460-2075.1993.tb05799.x
https://doi.org/10.1002/j.1460-2075.1993.tb05799.x
Autor:
J. E. Alés Martínez
Publikováno v:
Oncología (Barcelona) v.29 n.1 2006
SciELO España. Revistas Científicas Españolas de Ciencias de la Salud
instname
SciELO España. Revistas Científicas Españolas de Ciencias de la Salud
instname
The pharmacological prevention (chemoprevention) of breast cancer is the new challenge of modern medical oncology to deal with a kind of tumor that is the most frequent among the female population all over the world. The extension of the screening pr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cb7c0b83e790a8d82b655c938e63b30f
http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S0378-48352006000100003
http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S0378-48352006000100003
Autor:
J, Redón, J V, Lozano, M, de la Figuera, J C, Rodriguez, J, Garrido, J E, Alés-Martínez, I, Alvarez-Cantalapiedra, J, Velasco-Quintana
Publikováno v:
Journal of human hypertension. 9(2)
To study how changes in dietary salt influence the blood pressure (BP) of pharmacologically controlled hypertensive patients, we have selected from a large multicenter trial two subgroups of 14 and 16 patients who attained BP control (office DBP90 mm
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::b04f9d785b011c3309ccb823afdb3d26
https://pubmed.ncbi.nlm.nih.gov/7752177
https://pubmed.ncbi.nlm.nih.gov/7752177
Publikováno v:
Seminars in immunology. 4(3)
B cell tolerance is described as the absence of a measurable antibody forming response to an antigenic challenge. The establishment of antigen-specific tolerance requires, by definition, engagement of the B cell antigen-specific receptor. However, on
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::1021ec1cb22592fb851ae72dd1498b73
https://pubmed.ncbi.nlm.nih.gov/1627790
https://pubmed.ncbi.nlm.nih.gov/1627790
Publikováno v:
International archives of allergy and immunology. 97(4)
High doses of recombinant interleukin-2 (IL-2) may induce autoimmune lesions in patients receiving experimental cancer treatment. In most cases, the manifestation of autoaggression is transient and organ-specific, predominantly affecting the thyroid
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::47a261d39812aef5aaf15ee63a493f9b
https://pubmed.ncbi.nlm.nih.gov/1597345
https://pubmed.ncbi.nlm.nih.gov/1597345
Publikováno v:
Cellular immunology. 135(2)
We have utilized several B-cell lymphomas that are growth inhibited by anti-Ig reagents as models for tolerance induction. In a previous communication, we demonstrated that the growth inhibition by anti-Ig can be partially prevented by the recombinan
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::40961152b2c549c56e2ac7cbcc5e0be6
https://pubmed.ncbi.nlm.nih.gov/1828011
https://pubmed.ncbi.nlm.nih.gov/1828011
Publikováno v:
Cellular immunology. 127(2)
ECH408-1 is a murine B cell lymphoma expressing idiotypically and allotypically distinguishable transfected and endogenous IgD. Previously, we demonstrated that this cell line was not growth inhibited by antibodies directed at membrane IgD, but could
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::2a8cac2f2894dd31ff50eb128d07f500
https://pubmed.ncbi.nlm.nih.gov/2328538
https://pubmed.ncbi.nlm.nih.gov/2328538